Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hypertension: On the Pill? Tell your dentist

13.12.2004


Hypertension, a controllable and preventable disease (and more commonly known as high blood pressure), affects 1 in 4 American adults. Causes are unknown in 90 percent of all cases. However, the most common cause of secondary hypertension in women is oral contraceptive use, according to a report in the November/December issue of General Dentistry, the Academy of General Dentistry’s (AGD) clinical, peer-reviewed journal.



Up to five percent of women taking birth control pills that contain a high dose of estrogen (above 35 micrograms of ethinyl estradiol) may experience oral contraceptive-related high blood pressure, says Mary A. Aubertin, DMD, author of the report, who cites studies reported by the Association of Reproductive Health Professionals (ARHP) and in the journal, Circulation. High blood pressure may lead to heart disease and stroke. Discontinuing the use of birth control pills or switching to a lower estrogen dose can reduce blood pressure.

"These findings are important for women and will help dentists better understand how patients, including those on birth control pills, may be at risk to develop hypertension," says Dr. Aubertin.


Typically, hypertension produces no symptoms until blood pressures become extremely elevated. Symptoms of very high blood pressure include headaches, dizziness, confusion and tingling of the hands and feet. In addition to the use of birth control pills, dentists are learning that race, stress, obesity, smoking, heavy drinking, genetics, age and inactivity may be risk factors to develop the disease.

According to the American Heart Association (AHA), as many as 50 million Americans age sixty and above have hypertension. Of those people, 30 percent do not know they have it and 41 percent do not receive therapy. Only 34 percent have their blood pressure under control.

Last year, the National Heart, Lung and Blood Institute (NHLBI) recommended new guidelines to help professionals and public determine those at risk of high blood pressure. A new category called "prehypertension" explains that the risk for cardiovascular disease now is believed to begin when blood pressure is 115/75 millimeters of mercury (mm/Hg) instead of at 140/90. "Monitoring blood pressure at the dental office helps dentists become part of a patient’s health care team," says Dr. Aubertin. "Dentists want to educate the public to pay attention to and manage their blood pressure before complications occur."

Studies show that damage to arteries--and the risk for heart attack and stroke--actually begin to rise at 115/75. Medical experts issued new blood pressure guidelines:

If systolic (top) pressure is less than 120 and if diastolic (bottom) pressure is less than 80, you are normal. If systolic pressure is 120-139 or if diastolic pressure is 80–89, you are experiencing prehypertension. If systolic pressure is 140–159 or if diastolic pressure is 90–99 you are experiencing stage 1 hypertension. If systolic pressure is 160 or higher or if diastolic pressure is 100 or higher, you are in stage 2 hypertension.

Hypertensive patients have a few things they should be aware of at the dental office:

  • Know that blood pressure medications have oral side effects
  • Tell your dentist about every drug or herb you are taking, including over-the-counter medications
  • Avoid long or stressful appointments
  • Provide dentist with complete medical history
  • Ask your dentist for blood pressure screening

Jennifer Starkey | EurekAlert!
Further information:
http://www.agd.org

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Optical Nanoscope Allows Imaging of Quantum Dots

Physicists have developed a technique based on optical microscopy that can be used to create images of atoms on the nanoscale. In particular, the new method allows the imaging of quantum dots in a semiconductor chip. Together with colleagues from the University of Bochum, scientists from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute reported the findings in the journal Nature Photonics.

Microscopes allow us to see structures that are otherwise invisible to the human eye. However, conventional optical microscopes cannot be used to image...

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Rutgers scientists discover 'Legos of life'

23.01.2018 | Life Sciences

Seabed mining could destroy ecosystems

23.01.2018 | Earth Sciences

Transportable laser

23.01.2018 | Physics and Astronomy

VideoLinks Science & Research
Overview of more VideoLinks >>>